Insulin NovoNordisk NovoRapid Injektionslösung Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

insulin novonordisk novorapid injektionslösung

novo nordisk pharma ag - insulinum aspartum - injektionslösung - insulinum aspartum 100 u. corresp. 3.5 mg, glycerolum, phenolum, metacresolum, zinci chloridum, natrii chloridum, dinatrii phosphas dihydricus, natrii hydroxidum ad ph, acidum hydrochloridum ad ph, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 1.9 mg. - diabetes mellitus - biotechnologika

Insulin NovoNordisk NovoRapid Penfill Injektionslösung Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

insulin novonordisk novorapid penfill injektionslösung

novo nordisk pharma ag - insulinum aspartum - injektionslösung - insulinum aspartum 100 u. corresp. corresp. 3.5 mg, glycerolum, phenolum, metacresolum, zinci chloridum, natrii chloridum, dinatrii phosphas dihydricus, natrii hydroxidum ad ph, acidum hydrochloridum ad ph, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 1.9 mg. - diabetes mellitus - biotechnologika

Insulin NovoNordisk NovoRapid FlexPen Injektionslösung Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

insulin novonordisk novorapid flexpen injektionslösung

novo nordisk pharma ag - insulinum aspartum - injektionslösung - insulinum aspartum 100 u.i., corresp. 3.5 mg, glycerolum, zinci chloridum, dinatrii phosphas dihydricus, natrii chloridum, natrii hydroxidum ad ph, acidum hydrochloridum ad ph, phenolum, metacresolum, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 3.216 mg. - diabetes mellitus - biotechnologika

Insulin NovoNordisk NovoRapid FlexTouch Injektionslösung Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

insulin novonordisk novorapid flextouch injektionslösung

novo nordisk pharma ag - insulinum aspartum - injektionslösung - insulinum aspartum 100 u.i., glycerolum, zincum ut zinci chloridum, natrii phosphates, natrii chloridum, conserv.: phenolum 1.5 mg, metacresolum 1.72 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - diabetes mellitus - biotechnologika

Insulin NovoNordisk NovoRapid PumpCart 100 E/ml Injektionslösung Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

insulin novonordisk novorapid pumpcart 100 e/ml injektionslösung

novo nordisk pharma ag - insulinum aspartum - injektionslösung - insulinum aspartum 100 u., glycerolum, zinci chloridum, dinatrii phosphas dihydricus, natrii chloridum, natrii hydroxidum, acidum hydrochloridum, phenolum, metacresolum, aqua ad iniectabile ad solutionem pro 1 ml corresp. natrium 3.216 mg. - diabetes mellitus - biotechnologika

Fiasp ultra-fast-acting FlexTouch Injektionslösung Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

fiasp ultra-fast-acting flextouch injektionslösung

novo nordisk pharma ag - insulinum aspartum - injektionslösung - insulinum aspartum 600 nmol corresp. insulinum aspartum 100 u., glycerolum, zincum ut zinci acetas dihydricus, dinatrii phosphas dihydricus, arginini hydrochloridum, nicotinamidum, conserv.: phenolum 1.5 mg, metacresolum 1.72 mg, aqua ad iniectabile, q.s. ad solutionem pro 1 ml. - diabetes mellitus - biotechnologika

Fiasp ultra-fast-acting Penfill Injektionslösung Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

fiasp ultra-fast-acting penfill injektionslösung

novo nordisk pharma ag - insulinum aspartum - injektionslösung - insulinum aspartum 600 nmol corresp. insulinum aspartum 100 u., glycerolum, zincum ut zinci acetas dihydricus, dinatrii phosphas dihydricus, arginini hydrochloridum, nicotinamidum, conserv.: phenolum 1.5 mg, metacresolum 1.72 mg, aqua ad iniectabile, q.s. ad solutionem pro 1 ml. - diabetes mellitus - biotechnologika

Fiasp ultra-fast-acting Injektionslösung Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

fiasp ultra-fast-acting injektionslösung

novo nordisk pharma ag - insulinum aspartum - injektionslösung - insulinum aspartum 600 nmol corresp. insulinum aspartum 100 u., glycerolum, zincum ut zinci acetas dihydricus, dinatrii phosphas dihydricus, arginini hydrochloridum, nicotinamidum, conserv.: phenolum 1.5 mg, metacresolum 1.72 mg, aqua ad iniectabile, q.s. ad solutionem pro 1 ml. - diabetes mellitus - biotechnologika

Insulin aspart Sanofi Europäische Union - Deutsch - EMA (European Medicines Agency)

insulin aspart sanofi

sanofi winthrop industrie - insulin aspart - diabetes mellitus - drogen bei diabetes verwendet - insulin aspart sanofi is indicated for the treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above.

Kirsty (previously Kixelle) Europäische Union - Deutsch - EMA (European Medicines Agency)

kirsty (previously kixelle)

biosimilar collaborations ireland limited - insulin aspart - diabetes mellitus - drogen bei diabetes verwendet - kirsty is indicated for treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above.